Core Insights - TimesSquare Capital Management's "U.S. Focus Growth Strategy" reported a gross return of 4.00% and a net return of 3.78% for Q3 2025, outperforming the Russell Midcap Growth Index's return of 2.78% [1] - EMCOR Group, Inc. (NYSE:EME) was highlighted as a key stock, with a one-month return of 2.00% and a 52-week gain of 28.71%, closing at $623.65 per share with a market capitalization of $27.918 billion [2][3] Company Performance - EMCOR Group, Inc. reported consolidated revenues of $4.3 billion in Q3 2025, marking a 16.4% increase from Q3 2024 [4] - The company's strong performance was driven by significant growth in its US Electrical segment, particularly due to data center expansion, which contributed to a 21% stock increase [3] Investment Positioning - EMCOR Group is well-positioned to capture a significant share of large data center and manufacturing projects, supported by its scale and advanced capabilities in virtual design and construction [3] - Despite its potential, EMCOR is not among the top 30 most popular stocks among hedge funds, with 58 hedge fund portfolios holding its stock at the end of Q3 2025, up from 51 in the previous quarter [4]

Core Insights - TimesSquare Capital Management's "U.S. Focus Growth Strategy" reported a gross return of 4.00% and a net return of 3.78% for Q3 2025, outperforming the Russell Midcap Growth Index's return of 2.78% [1] - Cintas Corporation (NASDAQ:CTAS) is highlighted as a key stock, with a one-month return of 2.05% and a 52-week loss of 11.46%, closing at $187.53 per share with a market capitalization of $75.565 billion [2][4] Company Performance - Cintas Corporation reported better-than-expected fiscal first-quarter results, but its stock experienced an 8% pullback due to concerns regarding employment, industry pricing, and cost pressures [3] - In Q1 of fiscal 2026, Cintas Corporation's total revenue grew by 8.7% to $2.72 billion [4] Hedge Fund Interest - Cintas Corporation was held by 61 hedge fund portfolios at the end of Q3 2025, an increase from 57 in the previous quarter, indicating growing interest among institutional investors [4]

Core Viewpoint - TimesSquare Capital Management's "U.S. Focus Growth Strategy" reported positive returns across major asset classes in Q3 2025, with a strategy return of 4.00% (gross) and 3.78% (net), outperforming the Russell Midcap Growth Index's return of 2.78% [1] Company Overview - Martin Marietta Materials, Inc. (NYSE:MLM) is a building materials company that supplies aggregates and heavy-side building materials to the construction industry [2][3] - As of December 12, 2025, Martin Marietta's stock closed at $628.25 per share, with a market capitalization of $37.888 billion [2] Performance Metrics - Martin Marietta's one-month return was 6.49%, and its shares gained 14.79% over the last 52 weeks [2] - The company's shares rose 15% over the quarter following an asset swap deal with Quikrete, which involved the exchange of cement and ready-mix assets for aggregates operations across several states [3] Market Sentiment - Jim Cramer highlighted Martin Marietta Materials as a key player in the booming road building sector, although it is not among the 30 most popular stocks among hedge funds [4] - At the end of Q3 2025, 64 hedge fund portfolios held Martin Marietta, unchanged from the previous quarter [4]

Company Overview - Aurora Cannabis Inc. (NASDAQ:ACB) is recognized as one of the top sin stocks to consider for investment in 2026, with notable market growth in Europe and Australia [1] - The company operates in the cannabis industry, producing, distributing, and selling cannabis and cannabis-derived products, targeting both medical and consumer segments [4] Recent Developments - On December 2, Aurora's subsidiary, MedReleaf Australia, entered into a distribution agreement with Leafio, Montu Australia's wholesale arm, aimed at providing training materials for medical professionals and enhancing patient access to medical cannabis products across Australia [2] - Following this, on December 11, Aurora launched a new high-potency cannabis product named Black Jelly in the Polish medicinal market, which contains 27% THC and less than 1% CBD [3] - Black Jelly is produced in Aurora's Canadian facilities that are certified under GACP and EU-GMP standards, and it is now available to Polish prescribers [4] Product Portfolio - Aurora's medical cannabis portfolio includes several brands such as MedReleaf, CraftPlant, Aurora, Whistler Cannabis Co., and IndiMed, which will be marketed by Leafio [2] - The introduction of Black Jelly adds to the Cannabis flos Aurora range, which already includes products like Farm Gas and Sourdough [3]

Core Viewpoint - Wynn Resorts, Limited is positioned as a strong investment opportunity in the sin stock category for 2026, with JPMorgan raising its price target from $138 to $145 following positive developments in the UAE market [1]. Group 1: Financial Projections - JPMorgan's analysis suggests that the UAE is becoming a competitive market for attracting ultra-high-net-worth individuals, similar to Singapore, enhancing the outlook for Wynn Resorts [2]. - Macquarie indicates that the gross gaming revenues for the Wynn Al Marjan Island development could exceed $2 billion annually, reflecting a potentially conservative estimate [2]. - Non-gaming revenue from retail and other features is projected to reach between $200 million and $400 million yearly, contributing to the overall financial health of Wynn Resorts [3]. Group 2: Market Impact - The anticipated demand in Ras Al Khaimah is expected to outstrip hotel room supply, which may help maintain consistent EBITDA for Wynn Resorts into 2029 and beyond [3]. - Macquarie estimates that the developments at Wynn Al Marjan Island could increase WYNN's share price by $25 to $50, indicating strong market confidence in the project [3]. Group 3: Company Overview - Wynn Resorts, Limited operates as a luxury hotel and casino operator, known for its premium resort experiences and high-end properties located in Boston, Macau, and Las Vegas [4].

Group 1: Company Overview - Flutter Entertainment plc (NYSE:FLUT) operates as a sports betting and gaming company, offering a range of products including sportsbooks, iGaming products such as blackjack, roulette, slot machines, poker, and rummy, as well as lottery products and sports betting products [4] Group 2: Tax Increases and Financial Impact - The UK Budget announced significant tax increases for online gaming, raising the tax from 21% to 40% by 2026, which represents a 90% increase. Additionally, the sports betting duty will increase from 15% to 25% next year, a nearly 67% increase [2] - The UK Treasury expects these tax changes to generate an additional £1.1 billion per year in revenue by 2029 [2] - Benchmark has reaffirmed its Buy rating on Flutter but reduced its price target from $310 to $285, citing that medium-term profitability will be significantly impacted by these tax increases [1][3] Group 3: Mitigation Strategy - In response to the tax increases, Flutter's management has proposed a two-phase strategy that includes short-term cost-cutting initiatives and longer-term advantages expected from scale, operational savings, and potential market-share gains [3] - Despite these mitigation efforts, the combined effects of the tax rises on sports betting and iGaming represent a substantial structural change for the UK market [3]

Core Insights - Americold Realty Trust Inc. (NYSE:COLD) experienced a significant share price increase of 18.4% week-on-week, driven by seasonal demand for temperature-controlled services ahead of the Christmas season [1] - The company's stock price reached a high of $12.83 during intra-week trading, closing at $12.73, influenced by broader market optimism following a 25 basis point cut in the Federal Reserve's benchmark rate [2] Financial Performance - For the third quarter, Americold reported a widened attributable net loss of $11.37 million, a 207% increase from a loss of $3.7 million in the same period last year [5] - Total revenues decreased by 1.5% to $663.7 million from $674.17 million year-on-year, primarily due to lower volumes in the warehouse segment and a decline in transportation revenue [6] Future Outlook - The company reaffirmed its full-year 2025 outlook, targeting a revenue growth of 1 to 2% for the warehouse segment, while same-store revenues are projected to decline by up to 4% or remain flat year-on-year [3] - Non-same-store net operating income (NOI) is estimated to be between $7 million and $13 million, with transportation and management NOI expected to be in the range of $40 million to $44 million [4]

Core Insights - Wave Life Sciences Ltd. (NASDAQ: WVE) experienced a significant surge in share price, nearly tripling week-on-week, driven by positive results from its obesity drug clinical trial [1][2]. Clinical Trial Results - The first phase of the clinical trial for WVE-007 showed promising results, with a 4.5% total fat loss, 9.4% visceral fat reduction, and a 3.2% increase in lean mass over three months [3]. - No serious adverse reactions were reported during the trial, which contributed to investor confidence in the drug's safety and tolerability [3]. Future Expectations - Wave Life Sciences plans to release results from the second round of the clinical trial, which will include six-month data for the 240 mg single-dose cohort and three-month follow-up data for the 400 mg single-dose cohort [4][5]. - The company aims to evaluate WVE-007 as both a monotherapy and an add-on therapy for patients with higher BMI and related co-morbidities in phase 2 of the trial [5].

Group 1: Acquisition Details - SPX Technologies, Inc. announced a definitive agreement to acquire Crawford United Corporation for approximately $300 million, which is part of its expansion plans [1] - The acquisition will merge Crawford United's Commercial Air-Handling Equipment segment with SPX's HVAC segment, enhancing SPX's HVAC capabilities [1][3] - SPX intends to divest the Industrial & Transportation Products segment of Crawford United as it does not align with the company's long-term strategy [3] Group 2: Financial Performance - The Commercial Air-Handling Equipment segment of Crawford United reported $22.8 million in operating profit and $81.6 million in sales over the past 12 months ending September 30, 2025 [2] - SPX Technologies reported total revenue of $2.16 billion over the last 12 months, with a solid revenue growth of 12.6% [2] Group 3: Strategic Fit and Market Position - The acquisition is expected to strengthen SPX's ability to deliver end-to-end solutions to customers in various sectors, including healthcare, universities, and advanced manufacturing [4] - SPX Technologies operates as a supplier of infrastructure equipment, primarily serving the cooling, heating, ventilation, and detection & measurement markets [4]

Group 1 - Comfort Systems (NYSE:FIX) has been selected for inclusion in the S&P 500 index, effective before the market opens on December 22, replacing LKQ Corp., Mohawk Industries Inc., and Solstice Advanced Materials Inc. [1] - The stock price of Comfort Systems tends to rise leading up to the S&P inclusion, although interest may wane post-inclusion, as noted by market strategist Matt Maley [2] - Following a third-quarter earnings beat on October 24, Comfort Systems received upgrades from UBS and Stifel, resulting in a consensus buy rating with a median price target indicating a 15.21% upside from current levels [3] Group 2 - Comfort Systems USA, Inc. provides mechanical and electrical installation, maintenance, replacement, renovation, and repair services, operating through Electrical and Mechanical segments, and specializes in ventilation, air conditioning, and heating systems [4]